These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8481394)
41. Structural and functional properties of human and mouse apolipoprotein A-I. Gong EL; Tan CS; Shoukry MI; Rubin EM; Nichols AV Biochim Biophys Acta; 1994 Aug; 1213(3):335-42. PubMed ID: 8049247 [TBL] [Abstract][Full Text] [Related]
42. Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function. Chung BH; Anatharamaiah GM; Brouillette CG; Nishida T; Segrest JP J Biol Chem; 1985 Aug; 260(18):10256-62. PubMed ID: 4019511 [TBL] [Abstract][Full Text] [Related]
44. The transformation of nascent disc shaped high density lipoproteins into mature spherical high density lipoproteins: conformational analysis of apolipoprotein A-I in model intermediate particles. Talussot C; Ponsin G J Theor Biol; 1994 Jul; 169(2):143-52. PubMed ID: 7934079 [TBL] [Abstract][Full Text] [Related]
45. Acquired hypolipoproteinemia. De Buyzere M; Delanghe J; Labeur C; Noens L; Benoit Y; Baert J; Rosseneu M Clin Chem; 1992 May; 38(5):776-81. PubMed ID: 1582035 [TBL] [Abstract][Full Text] [Related]
46. Mechanism of action of gemfibrozil on lipoprotein metabolism. Saku K; Gartside PS; Hynd BA; Kashyap ML J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042 [TBL] [Abstract][Full Text] [Related]
47. Oxidation of methionine residues affects the structure and stability of apolipoprotein A-I in reconstituted high density lipoprotein particles. Sigalov AB; Stern LJ Chem Phys Lipids; 2001 Nov; 113(1-2):133-46. PubMed ID: 11687233 [TBL] [Abstract][Full Text] [Related]
48. Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I. Han M; Gillard BK; Courtney HS; Ward K; Rosales C; Khant H; Ludtke SJ; Pownall HJ Biochemistry; 2009 Feb; 48(7):1481-7. PubMed ID: 19191587 [TBL] [Abstract][Full Text] [Related]
49. Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome. Gordon SM; Li H; Zhu X; Tso P; Reardon CA; Shah AS; Lu LJ; Davidson WS J Proteomics; 2016 Sep; 146():184-94. PubMed ID: 27385375 [TBL] [Abstract][Full Text] [Related]
50. Characterization of lipoproteins containing a truncated form of apolipoprotein B, apolipoprotein B32. McCormick SP; Day WA; George PM Biochim Biophys Acta; 1995 Aug; 1258(1):49-56. PubMed ID: 7654780 [TBL] [Abstract][Full Text] [Related]
51. The C-terminal helix of human apolipoprotein AII promotes the fusion of unilamellar liposomes and displaces apolipoprotein AI from high-density lipoproteins. Lambert G; Decout A; Vanloo B; Rouy D; Duverger N; Kalopissis A; Vandekerckhove J; Chambaz J; Brasseur R; Rosseneu M Eur J Biochem; 1998 Apr; 253(1):328-38. PubMed ID: 9578492 [TBL] [Abstract][Full Text] [Related]
52. Apolipoprotein-lipid association in oxidatively modified HDL and LDL. Shoukry MI; Gong EL; Nichols AV Biochim Biophys Acta; 1994 Jan; 1210(3):355-60. PubMed ID: 8305491 [TBL] [Abstract][Full Text] [Related]
53. Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans. Andraski AB; Singh SA; Lee LH; Higashi H; Smith N; Zhang B; Aikawa M; Sacks FM Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2411-2430. PubMed ID: 31554421 [TBL] [Abstract][Full Text] [Related]
54. Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning. Pownall HJ; Hosken BD; Gillard BK; Higgins CL; Lin HY; Massey JB Biochemistry; 2007 Jun; 46(25):7449-59. PubMed ID: 17530866 [TBL] [Abstract][Full Text] [Related]
55. Copper- and malondialdehyde-induced modification of high density lipoprotein and parallel loss of lecithin cholesterol acyltransferase activation. Mazière JC; Myara I; Salmon S; Auclair M; Haigle J; Santus R; Mazière C Atherosclerosis; 1993 Dec; 104(1-2):213-9. PubMed ID: 8141845 [TBL] [Abstract][Full Text] [Related]
56. Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies. Segrest JP; Cheung MC; Jones MK J Lipid Res; 2013 Oct; 54(10):2733-44. PubMed ID: 23883582 [TBL] [Abstract][Full Text] [Related]
57. Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins. Rosales C; Gillard BK; Courtney HS; Blanco-Vaca F; Pownall HJ Biochemistry; 2009 Aug; 48(33):8070-6. PubMed ID: 19618959 [TBL] [Abstract][Full Text] [Related]
58. Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Silva RA; Huang R; Morris J; Fang J; Gracheva EO; Ren G; Kontush A; Jerome WG; Rye KA; Davidson WS Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12176-81. PubMed ID: 18719128 [TBL] [Abstract][Full Text] [Related]
59. Effects of protein oxidation on the structure and stability of model discoidal high-density lipoproteins. Jayaraman S; Gantz DL; Gursky O Biochemistry; 2008 Mar; 47(12):3875-82. PubMed ID: 18302337 [TBL] [Abstract][Full Text] [Related]
60. Detailed molecular model of apolipoprotein A-I on the surface of high-density lipoproteins and its functional implications. Segrest JP; Harvey SC; Zannis V Trends Cardiovasc Med; 2000 Aug; 10(6):246-52. PubMed ID: 11282302 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]